• Search
  • Login
  • Register
Menu
  • BJH
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > EHA 2019

Category

All
  • General
  • Healthy Living
  • Pharma News
  • Health of Tomorrow
  • Viewpoints
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View
  • Podcasts
  • Therapy
  • Editor's pick
  • Covid-19

EHA 2019

Brentuximab vedotin + AVD provides durable benefit in Hodgkin’s lymphoma patients

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • Corrigendum to “Recent advances in targeted therapies for patients with acute myeloid leukemia”
  • Gene therapy for von Willebrand Disease
  • FLT3 inhibitors after allogeneic haematopoietic stem cell transplantation in paediatric AML
  • Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS syndrome) with multiple thromboembolism events: A Belgian case report
  • Heterophilic antibodies as the cause of a false positive malaria rapid diagnostic test: A case report
  • Highlights from the 20th iwCLL
  • Journal scan
  • New haematology reimbursements in Belgium
EHA 2019

Acalabrutinib delays disease progression in patients with relapsed/refractory CLL

Read more
EHA 2019

Voxelotor induces robust improvements in anemia in patients with sickle cell disease

Read more
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2023